R.F.P.M. Kruitwagen

Zwimpfer, T. A., Fereday, S., Pandey, A., Ariyaratne, D., Jayawardana, M. W., Twomey, L., Laumont, C. M., Kennedy, C. J., Bolithon, A., Meagher, N. S., Milne, K., Hamilton, P., Alsop, J., Antoniou, A. C., Au-Yeung, G., Beckmann, M. W., Berrington de Gonzalez, A., Bisinotto, C., Blome, F., ... Et al. (2026). Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma. Nature Communications, 17(1), Article 4789. https://doi.org/10.1038/s41467-026-71134-3

Kiebach, J., Beijer, S., De Rooij, B. H., Pijnenborg, J. M. A., Vos, M. C., Boll, D., Kruitwagen, R. F. P. M., & Ezendam, N. P. M. (2026). Gynecological cancer survivors with higher levels of physical and psychological symptoms consume less fruits and vegetables. Annals of Behavioral Medicine, 60(1), Article kaaf008. https://doi.org/10.1093/abm/kaaf008

Laven, P., Wenzel, H. H. B., van der Aa, M. A., Lambrechts, S., & Kruitwagen, R. F. P. M. (2025). Impact of lymph node dissection and adjuvant chemotherapy on survival of patients with early-stage ovarian cancer: Update of a national cohort study. Gynecologic Oncology, 200, 51-57. https://doi.org/10.1016/j.ygyno.2025.07.010

Kessels, I., van Kuijk, S., Vergeldt, T., van Gestel, I., Spaans, W., Notten, K., Kruitwagen, R., & Weemhoff, M. (2025). The External Validation of a Multivariable Prediction Model for Recurrent Pelvic Organ Prolapse After Native Tissue Repair: A Prospective Cohort Study. Journal of Clinical Medicine, 14(2), Article 531. https://doi.org/10.3390/jcm14020531

Vrede, S. W., Van Weelden, W. J., Bulten, J., Gilks, C. B., Teerenstra, S., Huvila, J., Matias-Guiu, X., Gil-Moreno, A., Asberger, J., Sweegers, S., van der Putten, L. J. M., Küsters-Vandevelde, H. V. N., Reijnen, C., Colas, E., Hausnerová, J., Weinberger, V., Snijders, M. P. L. M., Vinklerova, P., Ravaggi, A., ... Pijnenborg, J. M. A. (2025). Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer. Gynecologic Oncology, 192, 15-23. https://doi.org/10.1016/j.ygyno.2024.10.028

Burg, L. C., Vermeulen, R. J., Bekkers, R. L. M., Kruitwagen, R. F. P. M., & Zusterzeel, P. L. M. (2024). The Cost-Effectiveness of Sentinel Lymph Node Mapping in High-Risk Endometrial Cancer. Cancers, 16(24), Article 4240. https://doi.org/10.3390/cancers16244240

van Wagensveld, L., Van Nyen, T., Annibali, D., Sonke, G. S., Kruitwagen, R. F. P. M., Amant, F., & Horlings, H. M. (2024). High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer. Oncologist, 29(9), e1231-e1234. https://doi.org/10.1093/oncolo/oyae161